A dichotomy in the lipophilicity of natural estrogens, xenoestrogens, and phytoestrogens.

Using two independent analyses, it is demonstrated that natural (e.g., estradiol) and some xenoestrogens (e.g., methoxychlor metabolite) are characterized by a lipophilic region that is absent in nonestrogens as well as in phytoestrogens. It is suggested that this lipophilic region affects binding to specific receptors and may, in fact, differentiate harmful from beneficial estrogens. ImagesFigure 1.

[1]  H S Rosenkranz,et al.  International Commission for Protection Against Environmental Mutagens and Carcinogens. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE. , 1994, Mutation research.

[2]  B. Ames,et al.  Second chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1984 and by the National Toxicology Program through May 1986. , 1987, Environmental health perspectives.

[3]  B. Ames,et al.  Chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1982. , 1986, Environmental health perspectives.

[4]  H S Rosenkranz,et al.  Identification of a 2-D geometric descriptor associated with non-genotoxic carcinogens and some estrogens and antiestrogens. , 1996, Mutagenesis.

[5]  H. Rosenkranz,et al.  The carcinogenicity of diethylstilbestrol: structural evidence for a non-genotoxic mechanism , 1996, Archives of Toxicology.

[6]  G. Klopman.  MULTICASE 1. A Hierarchical Computer Automated Structure Evaluation Program , 1992 .

[7]  H. Rosenkranz,et al.  A study of the structural basis of the carcinogenicity of tamoxifen, toremifene and their metabolites. , 1996, Mutation research.

[8]  B. Ames,et al.  The fifth plot of the Carcinogenic Potency Database: results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989. , 1993, Environmental health perspectives.

[9]  J. Katzenellenbogen,et al.  Bis(4-hydroxyphenyl)[2-(phenoxysulfonyl)phenyl]methane: isolation and structure elucidation of a novel estrogen from commercial preparations of phenol red (phenolsulfonphthalein) , 1988, Journal of medicinal chemistry.

[10]  M. Pike,et al.  A carcinogenic potency database of the standardized results of animal bioassays , 1984, Environmental health perspectives.

[11]  V. Jordan,et al.  Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture. , 1990, Cancer research.

[12]  B. Ames,et al.  Third chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1986 and by the National Toxicology Program through June 1987. , 1987, Environmental health perspectives.